Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Liabilities and Shareholders Equity (2018 - 2025)

NutriBand (NTRB) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 32.88% to $8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.2 million through Oct 2025, down 34.05% year-over-year, with the annual reading at $7.5 million for FY2025, 0.63% down from the prior year.
  • Liabilities and Shareholders Equity hit $8.4 million in Q4 2025 for NutriBand, down from $10.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $15.4 million in Q4 2021 to a low of $6.2 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $10.5 million across 5 years, with a median of $10.2 million in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 380.35% in 2021 and later tumbled 59.4% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $15.4 million in 2021, then plummeted by 30.84% to $10.7 million in 2022, then decreased by 20.12% to $8.5 million in 2023, then skyrocketed by 47.17% to $12.5 million in 2024, then tumbled by 32.88% to $8.4 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for NTRB at $8.4 million in Q4 2025, $10.2 million in Q3 2025, and $6.2 million in Q2 2025.